In summary, our results demonstrated that DLGAP1-AS1 could up-regulate CDK8 and LRP6 to activate Wnt/β-catenin pathway in HCC cells, thus promoting tumorigenesis and EMT. This evidence concerns the gene DLGAP1 and hepatocellular carcinoma.